|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
264,900,000 |
Market
Cap: |
8.27(B) |
Last
Volume: |
49,305,461 |
Avg
Vol: |
5,854,790 |
52
Week Range: |
$4.32 - $31.23 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 606 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
39,348 |
1,060,446 |
4,785,085 |
4,785,085 |
Total Sell Value |
$1,152,494 |
$23,992,060 |
$86,338,289 |
$86,338,289 |
Total People Sold |
4 |
5 |
5 |
5 |
Total Sell Transactions |
4 |
17 |
26 |
26 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Junius Daniel M |
Chief Executive Officer |
|
2016-01-04 |
4 |
OE |
$3.19 |
$17,277 |
D/D |
5,416 |
175,031 |
|
- |
|
Lambert John |
Executive Vice President |
|
2016-01-04 |
4 |
AS |
$13.20 |
$51,339 |
D/D |
(3,889) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2016-01-04 |
4 |
OE |
$3.19 |
$12,406 |
D/D |
3,889 |
110,746 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,003 |
169,615 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-12-01 |
4 |
AS |
$13.11 |
$71,025 |
D/D |
(5,416) |
170,618 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-12-01 |
4 |
OE |
$3.19 |
$17,277 |
D/D |
5,416 |
176,035 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-12-01 |
4 |
AS |
$13.11 |
$50,977 |
D/D |
(3,889) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-12-01 |
4 |
OE |
$3.19 |
$12,406 |
D/D |
3,889 |
110,746 |
|
- |
|
Morris Charles Q |
Executive VP & CDO |
|
2015-11-27 |
4 |
AS |
$14.00 |
$72,380 |
D/D |
(5,170) |
27,090 |
|
- |
|
Mitchell Dean J |
Director |
|
2015-11-17 |
4 |
B |
$12.51 |
$125,110 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-11-03 |
4 |
OE |
$4.29 |
$25,341 |
D/D |
5,907 |
170,618 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-11-02 |
4 |
AS |
$12.00 |
$65,964 |
D/D |
(5,497) |
159,812 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-11-02 |
4 |
OE |
$3.19 |
$17,535 |
D/D |
5,497 |
165,309 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-11-02 |
4 |
AS |
$11.73 |
$45,627 |
D/D |
(3,889) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-11-02 |
4 |
OE |
$3.19 |
$12,406 |
D/D |
3,889 |
110,746 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-10-30 |
4 |
OE |
$4.29 |
$24,621 |
D/D |
5,697 |
159,812 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-10-29 |
4 |
AS |
$12.01 |
$64,072 |
D/D |
(5,335) |
154,115 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-10-29 |
4 |
OE |
$3.19 |
$17,019 |
D/D |
5,335 |
159,450 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-10-01 |
4 |
AS |
$9.55 |
$37,126 |
D/D |
(3,889) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-10-01 |
4 |
OE |
$3.19 |
$12,406 |
D/D |
3,889 |
110,746 |
|
- |
|
Johnston David Brannon |
Chief Financial Officer |
|
2015-09-17 |
4 |
AS |
$15.00 |
$75,000 |
D/D |
(5,000) |
0 |
|
- |
|
Johnston David Brannon |
Chief Financial Officer |
|
2015-09-17 |
4 |
OE |
$10.79 |
$53,950 |
D/D |
5,000 |
5,000 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-09-09 |
4 |
OE |
$5.77 |
$28,267 |
D/D |
4,899 |
159,014 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-09-01 |
4 |
AS |
$13.15 |
$71,238 |
D/D |
(5,416) |
154,115 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2015-09-01 |
4 |
OE |
$3.19 |
$17,277 |
D/D |
5,416 |
159,531 |
|
- |
|
257 Records found
|
|
Page 9 of 11 |
|
|